StonvexLoading…
StonvexStonvexStonvexCore line items from CMG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-07-21 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $3.36B | $3.09B | $11.93B | $8.94B | $5.94B |
Operating Income | Not available | $397.06M | $1.94B | $1.52B | $1.04B |
Net Income | Not available | $302.82M | $1.54B | $1.20B | $436.13M |
EPS (Diluted) | $0.32 | $0.23 | $1.14 | $0.89 | $0.61 |
Total Assets | Not available | $8.80B | $8.99B | $9.28B | $9.27B |
Total Liabilities | Not available | $6.40B | $6.16B | $6.06B | $5.74B |
Cash & Equivalents | Not available | $246.64M | $350.55M | $698.74M | $844.52M |
Free Cash Flow OCF − CapEx | Not available | $471.02M | $1.45B | $1.22B | $813.01M |
Shares Outstanding | Not available | 1.30B | 1.34B | 1.35B | 1.36B |